HALB Share Price Performance
US$0.0024
-0.00 (-66.43%)
Price US$0.0024
Share PriceUS$0.0024
HALB Community Narratives
There are no narratives available yet.
Recent HALB News & Updates
No updates
Halberd Corporation Key Details
Last Reported Earnings
Apr 30, 2022
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Halberd Corporation Competitors
About HALB
- Founded
- 2009
- Employees
- n/a
- CEO
- WebsiteView website
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer’s and Parkinson’s disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
U.S. Market Performance
- 7 Days: 0.2%
- 3 Months: 12.2%
- 1 Year: 19.9%
- Year to Date: 7.6%
The Consumer Staples sector gained 3.2% while the market remained flat over the last week. As for the longer term, the market has risen 20% in the past 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading